Skip to content

Clinical trials

Leukemia, Myelomonocytic, Chronic trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Country / region: Spain Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20121
20131
20141
20162
20173
20181
20195
20204
20214
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated5
Active, not recruiting4
Recruiting3
Enrolling by invitation1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Astex Pharmaceuticals, Inc.2
Janssen Research & Development, LLC2
Taiho Oncology, Inc.2
Takeda2
Traws Pharma, Inc.2
AbbVie1
Aptose Biosciences Inc.1
Celgene1
Cogent Biosciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic28
Myelodysplastic Syndromes21
Leukemia, Myeloid, Acute18
Neoplasms5
Leukemia4
Anemia, Refractory, with Excess of Blasts3
Hematologic Diseases3
Myeloproliferative Disorders3
Recurrence3
Breast Neoplasms2

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.